Intuitive Surgical Inc. (ISRG): Health Services' Starring Winner Of The Day

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Intuitive Surgical ( ISRG) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole was unchanged today. By the end of trading, Intuitive Surgical rose $13.74 (2.8%) to $512.57 on light volume. Throughout the day, 343,651 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 545,300 shares. The stock ranged in a price between $500-$513.91 after having opened the day at $500 as compared to the previous trading day's close of $498.83. Other companies within the Health Services industry that increased today were: Biolase ( BIOL), up 13.3%, ImmunoCellular Therapeutics ( IMUC), up 6.2%, Grifols ( GRFS), up 5.9%, and Enzo Biochem ( ENZ), up 5.8%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $20.05 billion and is part of the health care sector. The company has a P/E ratio of 31.1, above the S&P 500 P/E ratio of 17.7. Shares are up 1.3% year to date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Intuitive Surgical a buy, no analysts rate it a sell, and three rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, Integra LifeSciences Holdings ( IART), down 11.1%, Sunshine Heart ( SSH), down 10.5%, Uroplasty ( UPI), down 9.4%, and American Shared Hospital ( AMS), down 8.2%, were all laggards within the health services industry with Boston Scientific ( BSX) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.